Cargando…

Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?

INTRODUCTION: Obesity is associated with increased incidence of ovarian (OC), cervical (CC) and endometrium cancer (EC). However, the impact of body composition (BC) on overall survival (OS), especially of visceral adipose tissue (VAT) is not yet understood. METHODS: In 189 women with gynecological...

Descripción completa

Detalles Bibliográficos
Autores principales: Nattenmüller, Johanna, Rom, Joachim, Buckner, Tom, Arvin, Jalal, Bau, Benedikt, Sohn, Christof, Kauczor, Hans-Ulrich, Schott, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893243/
https://www.ncbi.nlm.nih.gov/pubmed/29662648
http://dx.doi.org/10.18632/oncotarget.24667
_version_ 1783313280701300736
author Nattenmüller, Johanna
Rom, Joachim
Buckner, Tom
Arvin, Jalal
Bau, Benedikt
Sohn, Christof
Kauczor, Hans-Ulrich
Schott, Sarah
author_facet Nattenmüller, Johanna
Rom, Joachim
Buckner, Tom
Arvin, Jalal
Bau, Benedikt
Sohn, Christof
Kauczor, Hans-Ulrich
Schott, Sarah
author_sort Nattenmüller, Johanna
collection PubMed
description INTRODUCTION: Obesity is associated with increased incidence of ovarian (OC), cervical (CC) and endometrium cancer (EC). However, the impact of body composition (BC) on overall survival (OS), especially of visceral adipose tissue (VAT) is not yet understood. METHODS: In 189 women with gynecological malignancies (31 OC, 104 CC, 54 EC, mean age 62.9y; mean BMI 26.8 kg/m(2); median follow-up 30.7months) with routine staging CT-scans at baseline (mean interval: 4.3 months), densitometric quantification of total (TAT), visceral, and subcutaneous-fat-area (SAT), inter-muscular-fat-area (IMFA), and skeletal-muscle-index (SMI) was performed to analyze the impact of BC on survival. RESULTS: With a mean follow-up of 30.7 months 48 patients had died. We observed no significant differences regarding BMI, the adipose- and muscle-distribution between surviving and deceased women. Univariate analyses revealed no significant BC-parameter with impact on OS, which was confirmed by different multivariate models. A subgroup analysis of OC, CC and EC showed only a protective impact of SMI on survival in the subgroup of CC. CONCLUSIONS: Despite the increased incidence of gynecological malignancies in obese, we found no significant impact of BC including VAT on patient survival. Further studies with larger cohorts are needed to quantify BC and its metabolomic impact regarding treatment and prognosis.
format Online
Article
Text
id pubmed-5893243
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-58932432018-04-16 Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies? Nattenmüller, Johanna Rom, Joachim Buckner, Tom Arvin, Jalal Bau, Benedikt Sohn, Christof Kauczor, Hans-Ulrich Schott, Sarah Oncotarget Research Paper INTRODUCTION: Obesity is associated with increased incidence of ovarian (OC), cervical (CC) and endometrium cancer (EC). However, the impact of body composition (BC) on overall survival (OS), especially of visceral adipose tissue (VAT) is not yet understood. METHODS: In 189 women with gynecological malignancies (31 OC, 104 CC, 54 EC, mean age 62.9y; mean BMI 26.8 kg/m(2); median follow-up 30.7months) with routine staging CT-scans at baseline (mean interval: 4.3 months), densitometric quantification of total (TAT), visceral, and subcutaneous-fat-area (SAT), inter-muscular-fat-area (IMFA), and skeletal-muscle-index (SMI) was performed to analyze the impact of BC on survival. RESULTS: With a mean follow-up of 30.7 months 48 patients had died. We observed no significant differences regarding BMI, the adipose- and muscle-distribution between surviving and deceased women. Univariate analyses revealed no significant BC-parameter with impact on OS, which was confirmed by different multivariate models. A subgroup analysis of OC, CC and EC showed only a protective impact of SMI on survival in the subgroup of CC. CONCLUSIONS: Despite the increased incidence of gynecological malignancies in obese, we found no significant impact of BC including VAT on patient survival. Further studies with larger cohorts are needed to quantify BC and its metabolomic impact regarding treatment and prognosis. Impact Journals LLC 2018-03-27 /pmc/articles/PMC5893243/ /pubmed/29662648 http://dx.doi.org/10.18632/oncotarget.24667 Text en Copyright: © 2018 Nattenmüller et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Nattenmüller, Johanna
Rom, Joachim
Buckner, Tom
Arvin, Jalal
Bau, Benedikt
Sohn, Christof
Kauczor, Hans-Ulrich
Schott, Sarah
Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
title Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
title_full Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
title_fullStr Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
title_full_unstemmed Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
title_short Visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
title_sort visceral abdominal fat measured by computer tomography as a prognostic factor for gynecological malignancies?
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893243/
https://www.ncbi.nlm.nih.gov/pubmed/29662648
http://dx.doi.org/10.18632/oncotarget.24667
work_keys_str_mv AT nattenmullerjohanna visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT romjoachim visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT bucknertom visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT arvinjalal visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT baubenedikt visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT sohnchristof visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT kauczorhansulrich visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies
AT schottsarah visceralabdominalfatmeasuredbycomputertomographyasaprognosticfactorforgynecologicalmalignancies